brand names of glp 1 drugs Comparing Ozempic, Wegovy and Other GLP-1 Ads for GLP‑1 drugs are
Description
23% on placebo) and 63% experienced a BMI reduction of 10% (vs
Intranasal insulin reduces white matter hyperintensity progression in association with improvements in cognition and CSF biomarker profiles in mild cognitive impairment and alzheimers disease
Incidence of nausea, vomiting, and diarrhea associated with GLP-1 receptor agonists
vomiting & diarrhea)
10.1136/gut.46.5.622 108 SchirraJ.NicolausM.RoggelR.KatschinskiM.StorrM.WoerleH
